Investing

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

Thinkstock

When investors hear that the stock market just hit a new all-time high, it’s probably fairly easy to assume that this means almost all the individual stocks are probably at all-time highs as well. In a world of push and pull inside the nuances of each major equity indexes, that just isn’t in the case. In some ways, it can be far off-base to think that all the major stocks are even doing well.

The Dow Jones industrial average is still considered to be “the market” when the public considers the stock market gains or losses on any given day. In reality, the Dow uses an arcane index calculation that is still based solely on share price rather than on a company’s market capitalization. That means that if a theoretical Dow stock had a $300 share price and a $50 billion market value and another had a $30 share price and a $500 billion market value that the first would have 10 times the index weighting in the Dow over the latter having an implied 10 times the weighting in the S&P 500 and other cap-weighted indexes.

With stocks at all-time highs, it’s important to consider the winners and losers. In this case, many stocks in the Dow are still holding the index back from even stronger gains. Despite the index now above 27,400, it is still shy of our original Dow 28,000 target at the start of 2019.

Boeing Co. (NYSE: BA) has been in hot water over its 737 Max having two deadly crashes, with a host of delays on when the plane can return to service and potential cover-ups and finger-pointing in the months since those deadly crashes. With shares seeing a gain of 0.8% at $348.00 on Monday, the 52-week high and all-time high from earlier in 2019 is $446.01.

Caterpillar Inc. (NYSE: CAT) may be up 1.2% at $146.25 for a 52-week high, but it remains held back by the slower global growth and the China exposure. The stock now trades above its consensus analyst target price of $140.17 from Refinitiv, and Caterpillar briefly traded above $173 before adjusting for dividends (closer to $163 after adjusting for dividends) at the start of 2018.

Chevron Corp. (NYSE: CVX) and Exxon Mobil Corp. (NYSE: XOM) are a two-for-one review as their woes are so similar. Many investors don’t want to own oil stocks now, and whether oil is $100 or $30 a barrel, and whether they are valued at five times or 25 times earnings, may not change that. Chevron had a 3% gain to $119.95 on Monday, down from a 52-week high of 127.34 and a 2014 high above $130. Exxon’s gain of 1.5% to $70.68 on Monday is still handily down from its 52-week high of $83.75, but its adjusted all-time high was over $101 back in late 2013.

Cisco Systems Inc. (NASDAQ: CSCO) is a low weighting in the Dow due to a sub-$50 share price, but a gain of more than 1% to $47.67 on Monday was still over $10 short of its 52-week high of $58.26. The technology player has been shifting to a recurring revenue model, but it effectively has been shut out of new business in China. It’s hard to imagine that this was a more than $70 stock at the peak of the tech and dot-com bubble seen in 2000.

Goldman Sachs Group Inc. (NYSE: GS) may be back above its woes tied to scandals in Indonesia and may have recovered quite a bit in 2019, but a 0.8% gain to $219.21 is still quite short of its 52-week high of $234.06. Adjusting for dividends, its high at the very start of 2018 was closer to $268.

Intel Corp. (NASDAQ: INTC) has recovered handily from earlier losses in the year, and the 1.1% gain to $57.15 on Monday is almost within two dollars of its 52-week high of $59.59. Still, Intel was closer to $75 at the zenith of the technology and dot-com bubble in 2000. Its current share price is also above the consensus target price of $56.03.


International Business Machines Corp. (NYSE: IBM) has been a continued problem in technology. After hitting a high above $213 in early 2013, IBM now languishes under $137, even after close to a 1% gain on Monday. Just so this doesn’t feel like picking on the company over its sins in the not-so-distant past, IBM’s 52-week high is $152.95. The company has so far been unable to convince Wall Street that its largest-ever acquisition of Red Hat will have an immediate payoff.

Johnson & Johnson (NYSE: JNJ) was last seen up 0.3% at $131.67, but that’s down from a 52-week and all-time high of $148.99. Its exposure to legal woes via asbestos in talcum powder and potential exposure to the opioid crisis have weighed on the stock.

McDonald’s Corp. (NYSE: MCD) may be down closer to 3% at $188.85 after firing star CEO Steve Easterbrook over an improper but consensual relationship with an employee, but investors already had been ringing the register and taking profits ahead of the news. The prior close of $193.94 was down from a 52-week and all-time high of $221.93.

Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) are also featured as twofer due to the companies having some overlaps in the issues keeping the shares lower. The drug patent cliff is a never-ending worry, but so is the drug pricing and potential Medicare for All plan. After a 0.5% gain to $85.35, Merck’s 52-week high of $87.35 still pales in comparison to its high of closer to $96 back in 2000. Pfizer was last seen down three cents at $38.36, and its 52-week high of $46.47 should speak for itself.

3M Co. (NYSE: MMM) is a conglomerate that may still not be as troubled as General Electric, but its shareholders are in the midst of international business woes, slow corporate spending woes and even some newer environmental woes. For a company with over 50 straight years of dividend hikes, these are not the norm. Despite 3M shares having recovered more than 15% from lows seen earlier in the year, the last price gain of 1.7% to $173.00 is still down from a 52-week high of $219.75. 3M shares also hit an all-time high just above $250 at the start of 2018.

Travelers Companies Inc. (NYSE: TRV) may be the Dow stock people fail to remember as a Dow stock, but even a 0.4% gain to $131.25 on Monday is still down handily from its 52-week high of $155.09. The insurer’s consensus target price of $141.06 is still even about 10% lower than its high.

UnitedHealth Group Inc. (NYSE: UNH) is the largest private-pay health insurer in America, making it exposed to political targeting. Medicare for All is even a potential existential risk for the company. UnitedHealth shares were down 0.2% at $251.70 on Monday, down from a 52-week high of $287.94.

Walgreens Boots Alliance Inc. (NYSE: WBA), the newest member of the Dow, has seen its shares clobbered. Even after a 2.5% gain to $58.79 on Monday, its 52-week high of $86.31 puts it in perspective. Politicians targeting drug prices, industry efforts to modernize how patients get their medicine and for what price, and even legal woes tied to selling opioid medication, are all weighing on the retail pharmacy chain. Shares of Walgreens even peaked above $96 back in 2015, before adjusting for dividends.

Of the other 15 members of the Dow not mentioned, not every one of those is trading at all-time highs on the same day. The reality is that usually about 10 Dow components are driving the index higher at any given time.

It is important to consider that the members change within all indexes over time. The Dow is no exception. Here are some of the major stocks that have been booted out of the Dow over the past decade: General Electric (2018); AT&T (2015); Alcoa, Bank of America and Hewlett-Packard (2013); Kraft Foods (2012); Citigroup and General Motors (2009).

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.